drugset / Trial / NCT05316493
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.
Timeline
- Start
- 2022-06-13
- Primary completion
- 2026-02-28
- Completion
- 2027-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 52 mg | Other |
| Subject | Megestrol Acetate | Other / unclassified | 160 mg | Oral |